Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Single-Arm, Global Multi-Center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions With a Novel Paclitaxel-Coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis

NCT01927068 is registered in ClinicalTrials.gov with Spectranetics Corporation as lead sponsor.

NCT NCT01927068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01927068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Single-Arm, Global Multi-Center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions With a Novel Paclitaxel-Coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis
Lead sponsor
Spectranetics Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2013
Completion date
August 31, 2022
Enrollment
499 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease